What does the public record show about CRPS?

This page gathers public data on complex regional pain syndrome in one place: clinical trials from ClinicalTrials.gov, research papers from PubMed, diagnosis counts from California hospitals, and adverse event reports on pain stimulators from the Food and Drug Administration. Scripts refresh each dataset weekly, and every figure shows its source and retrieval date.

A painted brass microscope with a poppy and lupine.

How many clinical trials are studying CRPS?

ClinicalTrials.gov, the registry run by the U.S. National Library of Medicine, lists every registered study whose condition matches complex regional pain syndrome, reflex sympathetic dystrophy or causalgia. The counts below include studies anywhere in the world. The trial finder filters the open studies by location and treatment type.

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved . Search: condition matches "complex regional pain syndrome" OR "reflex sympathetic dystrophy" OR causalgia.

Which CRPS studies are enrolling at California sites?

The table lists CRPS studies that are open to enrollment and name at least one California site. Some enroll people with several chronic pain conditions, so the eligibility section of each study record decides who qualifies. A listing here or on ClinicalTrials.gov is not a recommendation of any study.

CRPS studies open to enrollment with a California site, as of November 20, 2026
StudyWhat is being testedPhaseCalifornia sitesStatus
Empowered Relief for CaregiversNCT07636980 · Stanford UniversityEmpowered Relief for Caregivers (ER-CY)No phase (device or behavioral)Palo AltoRecruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)NCT07210515 · Ambros Therapeutics, Inc.NeridronatePhase 3La Jolla, Napa, Pasadena, Santa Monica, TustinRecruiting
Closed-Loop Deep Brain Stimulation for Refractory Chronic PainNCT04144972 · University of California, San FranciscoMedtronic Summit RC+S or Percept RCNo phase (device or behavioral)San FranciscoRecruiting
TMS for Complex Regional Pain SyndromeNCT03137472 · Stanford UniversityTranscranial Magnetic Stimulation (TMS)No phase (device or behavioral)Redwood CityRecruiting
Observational Study of Ketamine Infusions for the Treatment of Chronic PainNCT05477004 · Theresa LiiKetamineNot statedStanfordEnrolling by invitation
Closed Loop Spinal Cord Stimulation for Complex Regional Pain SyndromeNCT06421350 · Scripps HealthSpinal Cord Stimulation DeviceNo phase (device or behavioral)La JollaRecruiting
Low-Dose Naltrexone for the Treatment of Complex Regional Pain SyndromeNCT02502162 · Stanford UniversityLDNNo phase (device or behavioral)Palo AltoRecruiting
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain SyndromeNCT06393101 · University of California, San DiegoBRC-002Phase 1La Jolla, San DiegoRecruiting

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved . Listing a study here is not a recommendation. A study's status can change after the retrieval date; confirm on ClinicalTrials.gov.

How much CRPS research is published each year?

PubMed, the National Library of Medicine's index of medical journals, has indexed between about 250 and 300 papers on CRPS in each recent year. The chart counts papers indexed under the subject heading for complex regional pain syndromes or naming CRPS or reflex sympathetic dystrophy in the title or abstract. The newest year is partial.

01503001994: 137 papers1995: 125 papers1996: 117 papers19961997: 145 papers1998: 145 papers1999: 117 papers2000: 153 papers20002001: 149 papers2002: 146 papers2003: 141 papers2004: 162 papers20042005: 149 papers2006: 179 papers2007: 178 papers2008: 199 papers20082009: 230 papers2010: 255 papers2011: 212 papers2012: 230 papers20122013: 248 papers2014: 284 papers2015: 271 papers2016: 271 papers20162017: 245 papers2018: 236 papers2019: 247 papers2020: 283 papers20202021: 292 papers2022: 253 papers2023: 267 papers2024: 262 papers20242025: 262 papers2026: 305 papers2026
Show the numbers
CRPS papers indexed in PubMed, by publication year
YearPapers
1994137
1995125
1996117
1997145
1998145
1999117
2000153
2001149
2002146
2003141
2004162
2005149
2006179
2007178
2008199
2009230
2010255
2011212
2012230
2013248
2014284
2015271
2016271
2017245
2018236
2019247
2020283
2021292
2022253
2023267
2024262
2025262
2026305

Source: PubMed, U.S. National Library of Medicine. Retrieved . The count for 2026 is partial: the year is not over and indexing lags publication.

What are the newest CRPS papers?

The list shows the most recently published CRPS papers in PubMed, newest first, with a link to each record. A listing is not an endorsement. Single studies, small studies and animal studies appear beside large trials, and a paper's place in this list says nothing about its quality.

  1. Oxidative stress drives disuse-induced chronic pain through sex-divergent immune-neural mechanismsOhmichi M et al. Pain, 2026 Dec 1. PMID 42833864
  2. Frequency and diagnostic yield of CRPS-I in TBI: a 12-year retrospective cohort study at a Level I trauma centerYoon SJ et al. Brain injury, 2026 Dec. PMID 42820681
  3. Thwarted credibility work and double binds in medically unexplained pain in Japan: a qualitative studyOkuhara T et al. PEC innovation, 2026 Dec. PMID 42774916
  4. Prediction of type 1 complex regional pain syndrome with the presence of diaschisis in hemiplegic supratentorial stroke patientsChoi SB et al. Topics in stroke rehabilitation, 2026 Dec. PMID 41992837
  5. Hyperbaric oxygen therapy: a novel treatment option in complex regional pain syndrome and other chronic pain conditionsHájek M et al. Medical gas research, 2026 Dec 1. PMID 41964598
  6. Clinical and Radiographic Factors Associated With Complex Regional Pain Syndrome Type I After Conservatively Treated Distal Radius FracturesMalkoç FE et al. Medical science monitor : international medical journal of experimental and clinical research, 2026 Nov 14. PMID 43031316
  7. Clinical indications for stellate ganglion block: beyond anaesthesiologyUrquijo G et al. Medicina clinica, 2026 Nov 13. PMID 43026058
  8. ACOEM Guidelines: Complex Regional Pain Syndrome (CRPS)Feinberg SD et al. Journal of occupational and environmental medicine, 2026 Nov 12. PMID 43019569
  9. 'To live again': a qualitative study of patients' experiences of amputation for therapy-resistant complex regional pain syndromevan der Spek DPC et al. The journal of pain, 2026 Nov 9. PMID 43003320
  10. Repetitive Transcranial Magnetic Stimulation in Pain Management: A Narrative Review of Randomized Controlled TrialsDoan HN et al. Journal of pain research, 2026. PMID 43011526
  11. Sensory data-driven classification of complex regional pain syndrome: interpreting disease duration. Comment on Br J Anaesth 2026; 137: 785-95Chen T et al. British journal of anaesthesia, 2026 Nov 6. PMID 42995048
  12. The Vertebral Nerve as a Selective Target for Upper Limb Sympathetic Blockade: Anatomy, Ultrasound-Guided Technique, and Proof of ConceptBuchholz B et al. Clinical anatomy (New York, N.Y.), 2026 Nov 5. PMID 42989586

Source: PubMed, U.S. National Library of Medicine. Retrieved . Listed newest first. A listing is not an endorsement of a paper's findings.

How often do California hospitals record a CRPS diagnosis?

The California Department of Health Care Access and Information publishes how many times each diagnosis code appears on hospital records each year. The first table counts CRPS type I codes in three settings. The counts are records, not people: one person admitted twice is counted twice, and care in a doctor's office is not counted at all.

Times a CRPS type I code (ICD-10-CM G90.5x) was recorded in California, by setting and year
YearHospital inpatient staysEmergency department visitsAmbulatory surgery visits
20201,6621,7681,446
20211,8361,7941,646
20221,6361,2931,265
20231,6871,4491,227
20241,6652,3381,129
20251,8202,3961,235

Source: California Department of Health Care Access and Information (HCAI), Diagnosis Code Frequency files. Retrieved . A count is the number of times a code was recorded on an encounter in that setting and year, as a principal or secondary diagnosis. One person can be counted more than once, and visits to doctors' offices are not included. These are not counts of people with CRPS.

The second table breaks the newest year of inpatient records down by code. The codes record which limb is affected. Causalgia codes are how the coding system records CRPS type II, which follows injury to a specific nerve.

CRPS and causalgia codes on California hospital inpatient records, 2025
ICD-10-CM codeWhat the code meansTimes recorded
G56.40Causalgia of unspecified upper limb7
G56.41Causalgia of right upper limb17
G56.42Causalgia of left upper limb11
G56.43Causalgia of bilateral upper limbs6
G57.70Causalgia of unspecified lower limb5
G57.71Causalgia of right lower limb22
G57.72Causalgia of left lower limb35
G57.73Causalgia of bilateral lower limbs16
G90.50Complex regional pain syndrome I, unspecified545
G90.511Complex regional pain syndrome I of right upper limb167
G90.512Complex regional pain syndrome I of left upper limb110
G90.513Complex regional pain syndrome I of upper limb, bilateral73
G90.519Complex regional pain syndrome I of unspecified upper limb28
G90.521Complex regional pain syndrome I of right lower limb202
G90.522Complex regional pain syndrome I of left lower limb261
G90.523Complex regional pain syndrome I of lower limb, bilateral179
G90.529Complex regional pain syndrome I of unspecified lower limb55
G90.59Complex regional pain syndrome I of other specified site200

Source: California Department of Health Care Access and Information (HCAI), Diagnosis Code Frequency files. Retrieved . A count is the number of times a code was recorded on an encounter in that setting and year, as a principal or secondary diagnosis. One person can be counted more than once, and visits to doctors' offices are not included. These are not counts of people with CRPS.

What has been reported to FDA about implanted pain stimulators?

Spinal cord stimulators and dorsal root ganglion stimulators are implanted for several chronic pain conditions, CRPS among them. Manufacturers, clinicians and patients report problems to the Food and Drug Administration. The tables count those reports. FDA cautions that reports are unverified, may be duplicated, and do not establish that a device caused an event.

Adverse event reports FDA received for spinal cord and dorsal root ganglion stimulators, by year
Year receivedReports
20109,419
201111,603
201219,004
201326,861
201422,099
201519,196
201620,484
201725,264
201831,006
201933,230
202030,895
202126,969
202225,436
202335,587
202437,470
202533,747
2026 (to date)28,410
What the 2025 reports described
Report typeReports
Injury27,179
Malfunction6,537
Death28
Other3

Source: openFDA device adverse event (MAUDE) and recall data, U.S. Food and Drug Administration. Retrieved . Report counts, not rates. FDA: adverse event reports are unverified, may be duplicated, and do not establish that a device caused the event. FDA does not publish how many devices were implanted. Most stimulators are implanted for conditions other than CRPS.

A report count is not a rate of harm, because FDA does not publish how many devices are implanted, and most implants are for conditions other than CRPS. The numbers are useful for seeing what kinds of problems are reported and for asking a surgeon informed questions before an implant.

Which pain stimulators have been recalled recently?

The list shows the ten most recent recalls FDA has recorded for spinal cord and dorsal root ganglion stimulators and their accessories, with the reason FDA lists for each. A recall can be a software correction or a notice to clinicians and does not always mean a device is removed from patients.

  1. Boston Scientific Neuromodulation Corporation, recall started September 30, 2026 (Open, Classified)Product: Nalu TD2 Therapy Disc with firmware, REF: 34014-001, and TD2 Patient Kit, REF: 74011, part of the Nalu Neurostimulation SystemReason FDA lists: Therapy Disc (TD) that powers and sends stimulation signals to an Implantable Pulse Generator (IPG), part of a neurostimulation system, has a firmware issue that causes the TD to attempt to restart, then fail, leading it to become non-functional, and if a secondary TD is unavailable, this may lead IPG to become non-functional, thus unable to inhibit transmission of pain signals.
  2. Boston Scientific Neuromodulation Corporation, recall started June 17, 2026 (Open, Classified)Product: INFINION CX LEAD KIT, 50CM, Model: SC-2317-50, Material: M365SC2317500; INFINION CX LEAD KIT, 70CM, Model: SC-2317-70, Material: M365SC2317700. part of the Boston Scientific Spinal Cord Stimulator (SCS) Systems.Reason FDA lists: Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.
  3. Boston Scientific Neuromodulation Corporation, recall started April 29, 2026 (Open, Classified)Product: Boston Scientific Model SC-4318, Clik X Anchor REF: M365SC43180Reason FDA lists: Sterile anchors my lack sterility assurance.
  4. Medtronic Neuromodulation, recall started December 3, 2025 (Open, Classified)Product: A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).Reason FDA lists: Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
  5. Medtronic Neuromodulation, recall started November 20, 2025 (Open, Classified)Product: Restore Clinician Programmer Application (CP App), Model A71100 used with the following programmers: CT900A PROG CT900A CLINICIAN TABLET US CT900B PROG CT900B CLINICIAN TABLET EU -UK CT900C PROG CT900C CLINICIAN TABLET Reason FDA lists: Software issue where a Device Reset message displayed on the app was unable to be cleared. In rare cases, this resulted in an inability to resume therapy, and the patient experienced a recurrence of underlying pain symptoms. Resolution would require surgical replacement of the INS.
  6. Abbott Medical, recall started October 6, 2025 (Open, Classified)Product: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400Reason FDA lists: There is a potential issue affecting Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generators (IPGs), Model 32400 and Liberta RC Deep Brain Stimulation (DBS) Implantable Pulse Generators (IPGs), Model 62400 . These devicess may experience a loss of communication with the Clinician Programmer (CP) and/or the Patient Controller (PC).
  7. Medtronic Neuromodulation, recall started March 4, 2025 (Open, Classified)Product: Stimulation RC Clinician Programmer Application, Model A71400, when used with the Inceptiv (Model 977119) and Intellis Pro (Model 977118) neurostimulatorsReason FDA lists: There is a software issue that can permanently disable communication with an implantable neurostimulator (INS) when a specific intraoperative programming sequence is used.
  8. Medtronic Neuromodulation, recall started September 18, 2024 (Open, Classified)Product: Medtronic Recharger Kits, RS6230, RS7230, and RS5220A, containing components WR9230 and WR9220A Recharger for rechargeable implantable neurostimulators. The Rechargers are used with Neurostimulator Inceptiv INS Model 97Reason FDA lists: The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.
  9. Medtronic Neuromodulation, recall started August 21, 2024 (Open, Classified)Product: Vanta Implantable Neurostimulator (INS), Model 977006Reason FDA lists: Model 977006 Vanta INS batterty life has depleted faster than HCPs or patients expected leading to outpatient reprogramming or earlier than anticipated surgical replacements.
  10. Boston Scientific Neuromodulation Corporation, recall started July 17, 2024 (Open, Classified)Product: WAVEWRITER ALPHA: Model: SC-1216, 16 IPG KIT, REF: M365SC12160; Model: SC-1232, 32 IPG KIT, REF: M365SC12320Reason FDA lists: Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset, which may lead to transient loss of stimulation; patients may experience undesired sensations when therapy turns off for approx. 10-15 seconds and then back on, which may lead patient to request surgical intervention for replacement or revision.

Source: openFDA device adverse event (MAUDE) and recall data, U.S. Food and Drug Administration. Retrieved . FDA lists 104 recalls under these product codes in all; the ten newest are shown.

Can I download and reuse this data?

Yes. Each dataset is published as a file that records its original source, the query used and the retrieval date: clinical trials, research output, California hospital diagnosis counts and stimulator reports and recalls. Reuse is welcome with a link to this page and credit to the original source named in the file.

Guides in this section

Common questions

No public dataset counts people with CRPS in California. The state's hospital data counts how many times a CRPS code was recorded on hospital, emergency and surgery center records, which is a different thing. One person can generate several records in a year, and people treated only in doctors' offices generate none. Population studies elsewhere estimate between 5.46 and 26.2 new cases per 100,000 people a year.

A scheduled job runs every Monday. It queries each public source, rewrites the dataset files, rebuilds the site and publishes the result. Each table and chart shows the date its data was retrieved. California's hospital files and FDA's report database are themselves updated on their own schedules, so a weekly refresh often finds no change in them.

The reports alone cannot answer that. FDA's adverse event database collects reports that have not been verified, can include duplicates, and cannot be turned into a rate because the number of implanted devices is not published. The reports show which problems are reported, such as inadequate pain relief, device migration, charging and battery problems, and infection. Clinical trials and a discussion with the implanting physician address how often they happen.

Sources

Every source below was opened and read for this page. The date is when it was last checked.

  1. ClinicalTrials.gov study registry and APIDataset · U.S. National Library of Medicine · checked
  2. PubMed and the NCBI E-utilitiesDataset · U.S. National Library of Medicine · checked
  3. Hospital Inpatient Diagnosis, Procedure, and External Cause Codes (Diagnosis Code Frequency files)Dataset · California Department of Health Care Access and Information · checked
  4. openFDA device adverse event and recall dataDataset · U.S. Food and Drug Administration · checked
  5. Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based studyStudy · Pain (Sandroni et al.), 2003 · checked
  6. The incidence of complex regional pain syndrome: a population-based studyStudy · Pain (de Mos et al.), 2007 · checked

Ask a lawyer about your CRPS case

Free case review. No fee unless we recover. A person from Wise Law reads every message.

What happened before the CRPS started? (optional)
Has a doctor diagnosed CRPS? (optional)
Or call (424) 235-7879

Submitting this form does not create an attorney-client relationship. An attorney-client relationship is formed only by a signed written fee agreement.

Text usCall